MannKind to Present at the JMP Securities Life Sciences Conference

Date : 06/12/2019 @ 2:00PM
Source : GlobeNewswire Inc.
Stock : Mannkind Corp. (MNKD)
Quote : 1.06  -0.01 (-0.93%) @ 5:00AM

MannKind to Present at the JMP Securities Life Sciences Conference

Mannkind Corp. (NASDAQ:MNKD)
Historical Stock Chart

2 Months : From May 2019 to Jul 2019

Click Here for more Mannkind Corp. Charts.

MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the JMP Securities Life Sciences Conference at 9:00 AM (ET) on June 19, 2019.  The conference is being held at The St. Regis in New York. 

Michael Castagna, Chief Executive Officer, of MannKind Corporation, will provide an overview of the Company's business during the live presentation.  Steven B. Binder, Chief Financial Officer, will participate in one-on-one meetings with investors who are registered to attend the conference. 

The presentation will be webcast live.  Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at http://www.mannkindcorp.com.  The webcast replay will remain available for 14 days following the live presentation.

About MannKind CorporationMannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company's first FDA-approved product and the only orally inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.

Company Contact:Rose AlinayaInvestor Relations818-661-5000ir@mannkindcorp.com

Source: MannKind Corporation

 

Latest MNKD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.